Company: DERM
Filing Date: 2025-08-28
Form Type: 424B3
Source: 0001104659-25-084876
Chunk: 10

Company: Journey Medical Corp
Filing Date: 2025-08-28
Form: 424B3
Chunk 10
---
 broad discretion with respect to the use of proceeds of this offering, including for any of the purposes described in the section of this prospectussupplement titled “ Use of Proceeds.” You will be relying on the judgment of our management regarding the application of the proceeds of this offering. The results and effectiveness of the use of proceeds are uncertain, and we could spend the proceeds in ways that you do not agree with or that do not improve our results of operations or enhance the value of our common stock. Our failure to apply these funds effectively could have a material adverse effect on our business, delay the development of our product candidates, and cause the price of our common stock to decline.

It is not possible to predict the actual number of shares we will sell under the Sales Agreement, or the gross proceeds resulting from those sales.

Subject to certain limitations in the Sales Agreement
and compliance with applicable law, we have the discretion to deliver a placement notice to either Agent or both Agents at any time throughout
the term of the Sales Agreement. The number of shares that are sold through the applicable Agent after delivering a placement notice will
fluctuate based on a number of factors, including the limits we set with such Agent in any applicable placement notice and the demand
for our common stock during the sales period. Because the price per share of each share sold will fluctuate during the sales period, it
is not currently possible to predict the gross proceeds to be raised in connection with those sales, if any.

<div align='center'>S-6</div>

The common stock offered hereby will be sold in “at the market offerings,” and investors who buy shares at different times will likely pay different prices.

Investors who purchase shares in this offering
at different times will likely pay different prices, and so they may experience different levels of dilution and different outcomes in
their investment results. We will have discretion, subject to market demand, to vary the timing, prices, and numbers of shares sold in
this offering. In addition, there is no minimum or maximum sales price for shares to be sold in this offering. Investors may experience
a decline in the value of the shares they purchase in this offering as a result of sales made at prices lower than the prices they paid.

Future sales of our common stock, or the perception that such future sales may occur, may cause our stock price to decline.

Sales of a substantial number of shares of our
common stock in the public market, or the perception that these sales could occur, following this offering could cause